Institute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China.
Nat Commun. 2022 May 6;13(1):2513. doi: 10.1038/s41467-022-29772-w.
Therapeutic interventions of hepatic ischemia-reperfusion injury to attenuate liver dysfunction or multiple organ failure following liver surgery and transplantation remain limited. Here we present an innovative strategy by integrating a platinum nanoantioxidant and inducible nitric oxide synthase into the zeolitic imidazolate framework-8 based hybrid nanoreactor for effective prevention of ischemia-reperfusion injury. We show that platinum nanoantioxidant can scavenge excessive reactive oxygen species at the injury site and meanwhile generate oxygen for subsequent synthesis of nitric oxide under the catalysis of nitric oxide synthase. We find that such cascade reaction successfully achieves dual protection for the liver through reactive oxygen species clearance and nitric oxide regulation, enabling reduction of oxidative stress, inhibition of macrophage activation and neutrophil recruitment, and ensuring suppression of proinflammatory cytokines. The current work establishes a proof of concept of multifunctional nanotherapeutics against ischemia-reperfusion injury, which may provide a promising intervention solution in clinical use.
治疗性干预肝缺血再灌注损伤,以减轻肝手术后和移植后的肝功能障碍或多器官衰竭仍然有限。在这里,我们提出了一种创新策略,即将铂纳米抗氧化剂和诱导型一氧化氮合酶整合到基于沸石咪唑酯骨架-8 的混合纳米反应器中,以有效预防缺血再灌注损伤。我们表明,铂纳米抗氧化剂可以在损伤部位清除过多的活性氧,同时在一氧化氮合酶的催化下产生氧气,用于随后的一氧化氮合成。我们发现,这种级联反应通过清除活性氧和调节一氧化氮成功地为肝脏提供了双重保护,从而降低氧化应激、抑制巨噬细胞激活和中性粒细胞募集,并确保抑制促炎细胞因子。本工作建立了一种针对缺血再灌注损伤的多功能纳米治疗的概念验证,这可能为临床应用提供一种有前途的干预解决方案。